We are live on
!
Find out more
CCM
CAAS Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
1.45%
This Fund
S&P 500
This Quarter
Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
(+145%)
Cap. Flow
+$4.78B
Cap. Flow
% of AUM
45.54%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$153M |
| 2 |
Sunrun
RUN
|
+$94.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$83.8M |
| 4 |
Dynatrace
DT
|
+$67.2M |
| 5 |
Consolidated Edison
ED
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$71.8M |
| 2 |
10x Genomics
TXG
|
+$62.3M |
| 3 |
Caesars Entertainment
CZR
|
+$60.8M |
| 4 |
Denali Therapeutics
DNLI
|
+$53.1M |
| 5 |
PENN Entertainment
PENN
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Healthcare | 6.25% |
| 3 | Communication Services | 2.7% |
| 4 | Consumer Discretionary | 2.07% |
| 5 | Financials | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
CALL
Nike
NKE
$61.9B
| $22.1M | 0.21% |
+156,100
| New | +$20.7M |
|
|
SYNH
102
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22M | 0.21% |
323,325
-303,333
| -48% | -$18.9M |
|
103
CALL
ServiceNow
NOW
$115B
| $22M | 0.21% |
+200,000
| New | +$20.8M |
|
104
PUT
Micron Technology
MU
$930B
| $21.4M | 0.2% |
285,000
| – | – |
|
105
CALL
Carvana
CVNA
$68.6B
| $21.3M | 0.2% |
+445,000
| New | +$20.3M |
|
106
PUT
ExxonMobil
XOM
$644B
| $21M | 0.2% |
510,300
+200,500
| +65% | +$7.52M |
|
107
C3.ai
AI
$1.43B
| $20.8M | 0.2% |
+150,000
| New | +$20.1M |
|
108
PUT
Sarepta Therapeutics
SRPT
$1.57B
| $20.7M | 0.2% |
+121,700
| New | +$18M |
|
|
109
CALL
Sarepta Therapeutics
SRPT
$1.57B
| $20.7M | 0.2% |
+121,300
| New | +$18M |
|
110
PUT
SLB Ltd
SLB
$73.6B
| $20.2M | 0.19% |
927,200
+2,200
| +0.2% | +$41.5K |
|
|
PTVE
111
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $20.2M | 0.19% |
1,112,413
-770,876
| -41% | -$11.9M |
|
112
PUT
TSMC
TSM
$2.1T
| $20.2M | 0.19% |
184,800
-75,500
| -29% | -$7.16M |
|
113
Boeing
BA
$171B
| $20M | 0.19% |
93,405
+68,697
| +278% | +$13.2M |
|
114
CALL
Goldman Sachs
GS
$300B
| $19.8M | 0.19% |
+75,000
| New | +$16.7M |
|
115
PUT
Teladoc Health
TDOC
$1.22B
| $19.7M | 0.19% |
98,700
+97,500
| +8,125% | +$19.8M |
|
116
CALL
Johnson & Johnson
JNJ
$618B
| $19.7M | 0.19% |
+125,000
| New | +$18.4M |
|
117
Maravai LifeSciences
MRVI
$969M
| $19.6M | 0.19% |
+700,000
| New | +$19.5M |
|
|
FTOCU
118
DELISTED
FTAC Olympus Acquisition Corp. Unit
FTOCU
| $19.6M | 0.19% |
1,800,000
| – | – |
|
119
PUT
CF Industries
CF
$19.2B
| $19.4M | 0.18% |
500,000
| – | – |
|
120
Sotera Health
SHC
$5.09B
| $19.2M | 0.18% |
+700,000
| New | +$18.8M |
|
|
PARA
121
PUT
DELISTED
Paramount Global Class B
PARA
| $19M | 0.18% |
+511,100
| New | +$16.4M |
|
|
122
PUT
Nike
NKE
$61.9B
| $18.9M | 0.18% |
+133,900
| New | +$17.7M |
|
123
F5
FFIV
$22.9B
| $18.9M | 0.18% |
+107,160
| New | +$16.3M |
|
|
MIC
124
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $18.8M | 0.18% |
+500,000
| New | +$15.4M |
|
125
CALL
Southwest Airlines
LUV
$22B
| $18.6M | 0.18% |
+400,000
| New | +$17.3M |
|
Similar funds
CIG
TAM
WCF
CHP
SWC
KTA
LC
SBIA
CAAS Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.
- CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
- CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
- CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
- CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
- CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
- CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
- CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.
Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.